Emerging Trends in Bioanalytical Methods for Drug Development

Abstract

Bioanalytical methods are fundamental to the assessment of pharmacokinetics, bioavailability, and therapeutic efficacy of new drugs. Recent developments in Liquid Chromatography-Mass Spectrometry (LC-MS/MS), Capillary Electrophoresis, and Enzyme-Linked Immunosorbent Assays (ELISA) have significantly improved bioanalytical performance. This paper explores innovations in sample preparation, microextraction, and biosensor-based analytical systems. Emphasis is placed on the miniaturization of instruments and the automation of bioanalytical workflows. The integration of bioanalytical methods with in-silico modeling and pharmacometric analysis has accelerated drug discovery and development timelines. This study further highlights regulatory expectations for bioanalytical method validation, including accuracy, precision, selectivity, and robustness. The convergence of advanced analytical platforms and computational tools offers new possibilities for personalized medicine and targeted drug delivery.

KEYWORDS: - Bioanalysis, LC-MS/MS, Pharmacokinetics, Biosensors, Method Validation